Literature DB >> 9016841

Upregulation of (+)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin binding following intracerebroventricular administration of a nitric oxide generator.

D R Wallace, R M Booze.   

Abstract

Nitric oxide modulation of dopamine D2 and D3 receptor binding was examined using [125I]epidepride (D2) and (+)7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin ([3H](+)-7-OH-DPAT, D3). Nitric oxide, generated by i.c.v. injection of S-nitroso-N-acetyl-penicillamine (SNAP; 5 microg or 10 microg), significantly increased the density of [3H](+)-7-OH-DPAT binding sites (39% and 134%, respectively) in the striatum 24 hours post-injection in the absence of Gpp(NH)p, representing an upregulation of either D3 receptors or high affinity D2 receptors. In the presence of 10 microM Gpp(NH)p, D3 receptor upregulation was maintained in both the 5 microg (increased 35%) and 10 microg SNAP (increased 44%) groups. [3H](+)-7-OH-DPAT binding was reduced in both striatum and nucleus accumbens in the presence of 10 microM Gpp(NH)p compared to binding in the absence of Gpp(NH)p, suggesting an upregulation of D3 receptors. Administration of SNAP did not alter total specific [125I]epidepride binding in either brain region. These data suggest that; 1) D3 receptor density is modified following nitric oxide generation, and 2) the density of high affinity D2 receptors identified by [3H](+)-7-OH-DPAT increases in the striatum, but decreases in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016841     DOI: 10.1023/a:1027311506504

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.

Authors:  R K Sunahara; H C Guan; B F O'Dowd; P Seeman; L G Laurier; G Ng; S R George; J Torchia; H H Van Tol; H B Niznik
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

2.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

3.  Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand.

Authors:  G Damsma; T Bottema; B H Westerink; P G Tepper; D Dijkstra; T A Pugsley; R G MacKenzie; T G Heffner; H Wikström
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

4.  Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.

Authors:  R M Booze; D R Wallace
Journal:  Synapse       Date:  1995-01       Impact factor: 2.562

5.  Regulation of [3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors.

Authors:  L L Werling; H M Jacocks; P N McMahon
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

6.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

7.  Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.

Authors:  V L Dawson; T M Dawson; D A Bartley; G R Uhl; S H Snyder
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

8.  Nitric oxide induces calcium-dependent [3H]dopamine release from striatal slices.

Authors:  G Lonart; K L Cassels; K M Johnson
Journal:  J Neurosci Res       Date:  1993-06-01       Impact factor: 4.164

9.  [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.

Authors:  A M Gonzalez; D R Sibley
Journal:  Eur J Pharmacol       Date:  1995-01-05       Impact factor: 4.432

10.  Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP.

Authors:  R Guevara-Guzman; P C Emson; K M Kendrick
Journal:  J Neurochem       Date:  1994-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.